Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
JAMA|September 9, 2015
Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research AwardJames P Allison
Cell|September 12, 2015
CheckpointsJames P Allison
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsP'ng Loke, James P Allison
Science (New York, N.Y.)|April 4, 2015
The future of immune checkpoint therapyPadmanee Sharma, James P Allison
Science Translational Medicine|November 9, 2022
Immune checkpoint therapy: Forging aheadPadmanee Sharma, James P Allison
Nature Reviews. Immunology|July 2, 2025
Tumour cells mimic erythroblasts to hijack iron from bone marrow macrophagesMehdi Chaib, James P Allison
The Journal of Clinical Investigation|October 4, 2006
To be or not to be B7Xingxing Zang, James P Allison
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The B7 family and cancer therapy: costimulation and coinhibitionXingxing Zang, James P Allison
Nature Reviews. Immunology|January 12, 2020
Dissecting the mechanisms of immune checkpoint therapyPadmanee Sharma, James P Allison
Nature Reviews. Immunology|November 26, 2025
Local T<sub>reg</sub> cell loss reprogrammes systemic antitumour immunity without breaking toleranceMehdi Chaib, James P Allison
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
JAMA|September 9, 2015
Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research AwardJames P Allison
Cell|September 12, 2015
CheckpointsJames P Allison
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2003
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsP'ng Loke, James P Allison
Science (New York, N.Y.)|April 4, 2015
The future of immune checkpoint therapyPadmanee Sharma, James P Allison
Science Translational Medicine|November 9, 2022
Immune checkpoint therapy: Forging aheadPadmanee Sharma, James P Allison
Nature Reviews. Immunology|July 2, 2025
Tumour cells mimic erythroblasts to hijack iron from bone marrow macrophagesMehdi Chaib, James P Allison
The Journal of Clinical Investigation|October 4, 2006
To be or not to be B7Xingxing Zang, James P Allison
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The B7 family and cancer therapy: costimulation and coinhibitionXingxing Zang, James P Allison
Nature Reviews. Immunology|January 12, 2020
Dissecting the mechanisms of immune checkpoint therapyPadmanee Sharma, James P Allison
Nature Reviews. Immunology|November 26, 2025
Local T<sub>reg</sub> cell loss reprogrammes systemic antitumour immunity without breaking toleranceMehdi Chaib, James P Allison
Pageof 23